価格表

在庫・価格 : 2025年04月25日 20時04分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CD44, Mouse-Mono(MEM-263)
データシート※最新のデータシートでない場合があります
MAB3838 ABNアブノヴァ
Abnova Corporation
100 μg ¥70,000
(未発注)
追加

在庫・価格 : 2025年04月25日 20時04分 現在

Anti-CD44, Mouse-Mono(MEM-263)

  • 商品コード:MAB3838
  • メーカー:ABN
  • 包装:100μg
  • 価格: ¥70,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Subramaniam V et al. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells. Exp. Mol. Pathol. 2007 Dec;83(3):341-6
Subramaniam V et al
2007/01/01
PubMed
2 Subramaniam V et al. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation. Exp. Mol. Pathol. 2007 Oct;83(2):207-15
Subramaniam V et al
2007/01/01
PubMed
3 Li L et al. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin. Cancer Res. 2013 Dec;19(24):6703-15
Li L et al
2013/01/01
PubMed
4 Qin J et al. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival. Int J Clin Exp Pathol 2014;7(6):3235-44
Qin J et al
2014/01/01
PubMed
5 Wu CL et al. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer. BMC Cancer 2015 Nov;15:903
Wu CL et al
2015/01/01
PubMed
6 Zeng H et al. Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells. Int. J. Oncol. 2017 Aug;51(2):445-455
Zeng H et al
2017/01/01
PubMed
7 Fan XY et al. Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy <i>via</i> targeting pancreatic cancer stem cells. Am J Transl Res 2019;11(6):3543-3554
Fan XY et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Subramaniam V et al. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells. Exp. Mol. Pathol. 2007 Dec;83(3):341-6
    Subramaniam V et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Subramaniam V et al. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation. Exp. Mol. Pathol. 2007 Oct;83(2):207-15
    Subramaniam V et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Li L et al. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin. Cancer Res. 2013 Dec;19(24):6703-15
    Li L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Qin J et al. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival. Int J Clin Exp Pathol 2014;7(6):3235-44
    Qin J et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Wu CL et al. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44&#x3BD; is an indicator for recurrence in advanced cancer. BMC Cancer 2015 Nov;15:903
    Wu CL et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zeng H et al. Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells. Int. J. Oncol. 2017 Aug;51(2):445-455
    Zeng H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Fan XY et al. Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy <i>via</i> targeting pancreatic cancer stem cells. Am J Transl Res 2019;11(6):3543-3554
    Fan XY et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed